Tigecycline is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Xellia Pharmaceuticals Usa Llc. The primary component is Tigecycline.
| Product ID | 70594-035_996993f9-86d3-4bd1-a92e-d6b19643e6bd |
| NDC | 70594-035 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tigecycline |
| Generic Name | Tigecycline |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-02-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA205722 |
| Labeler Name | Xellia Pharmaceuticals USA LLC |
| Substance Name | TIGECYCLINE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Tetracycline-class Antibacterial [EPC],Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2020-02-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA205722 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-02-01 |
| Marketing Category | ANDA |
| Application Number | ANDA205722 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-02-01 |
| Ingredient | Strength |
|---|---|
| TIGECYCLINE | 50 mg/1 |
| SPL SET ID: | 4183ef14-7db7-4fe3-978b-a35b1d29f378 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0781-3481 | Tigecycline | Tigecycline |
| 16729-364 | TIGECYCLINE | TIGECYCLINE |
| 55150-228 | Tigecycline | Tigecycline |
| 60505-6098 | Tigecycline | TIGECYCLINE |
| 63323-960 | Tigecycline | Tigecycline |
| 70121-1647 | Tigecycline | Tigecycline |
| 70594-035 | Tigecycline | Tigecycline |
| 71288-019 | Tigecycline | Tigecycline |
| 0008-4990 | Tygacil | TIGECYCLINE |
| 0008-4994 | Tygacil | TIGECYCLINE |